Abstract: The present disclosure is directed to a titanium dioxide scaffold provided with a nanoporous outer layer which can function as a cortical wall, inhibiting growth of soft tissue into the scaffold and increasing its mechanical strength. The disclosure is also directed to a process for producing such a nanoporous outer layer and the application of the titanium dioxide scaffold with the nanoporous outer layer as a medical implant.

Abstract: The present document is directed to medical implants in the form of titanium dioxide scaffolds. Disclosed is a method for producing titanium dioxide scaffolds having an increased mechanical strength by recoating the titanium dioxide scaffold with a low viscosity titanium dioxide slurry in a vacuum infiltration process followed by sintering of the scaffold. The document is also directed to the recoated titanium dioxide scaffolds produced and their uses as medical implants.

Abstract: The present document is directed to a titanium dioxide scaffold comprising a hydrogel coating comprising a biologically active substance. Also disclosed is a method for producing a thin hydrogel coating on a titanium dioxide scaffold and uses of the hydrogel coated scaffolds as medical implants.

Abstract: A calcium phosphate cement composition that includes the following two components: A) one or several calcium phosphate powders suspended in an aqueous solution including inhibitor cations inhibiting a reaction of the calcium phosphate powders with water, the inhibitor cations being selected from Mg2+, Sr2+ and Ba2+ at a concentration greater than 0.01 M; and B) an aqueous solution including Ca2+ cations at a concentration greater than 0.1 M. This calcium phosphate cement compositions can be safely stored for years yet still retain its full reactivity when mixed.

Abstract: A calcium phosphate cement composition that includes the following two components: A) one or several calcium phosphate powders suspended in an aqueous solution including inhibitor cations inhibiting a reaction of the calcium phosphate powders with water, the inhibitor cations being selected from Mg2+, Sr2+ and Ba2+ at a concentration greater than 0.01 M; and B) an aqueous solution including Ca2+ cations at a concentration greater than 0.1 M. This calcium phosphate cement compositions can be safely stored for years yet still retain its full reactivity when mixed.

Abstract: The present document is directed to a titanium dioxide scaffold comprising a hydrogel coating comprising a biologically active substance. Also disclosed is a method for producing a thin hydrogel coating on a titanium dioxide scaffold and uses of the hydrogel coated scaffolds as medical implants.

Abstract: The present disclosure is directed to a titanium dioxide scaffold provided with a nanoporous outer layer which can function as a cortical wall, inhibiting growth of soft tissue into the scaffold and increasing its mechanical strength. The disclosure is also directed to a process for producing such a nanoporous outer layer and the application of the titanium dioxide scaffold with the nanoporous outer layer as a medical implant.

Abstract: The present document is directed to medical implants in the form of titanium dioxide scaffolds. Disclosed is a method for producing titanium dioxide scaffolds having an increased mechanical strength by recoating the titanium dioxide scaffold with a low viscosity titanium dioxide slurry in a vacuum infiltration process followed by sintering of the scaffold. The document is also directed to the recoated titanium dioxide scaffolds produced and their uses as medical implants.

Abstract: The present document is directed to medical prosthetic devices used for implantation to replace and/or restore lost functions in a body. The document discloses a method for producing an alginate coated titanium dioxide scaffold wherein the alginate coating optionally comprises a biologically active substance.